Trifluoroacetic acid → HCID 69892979, Verbindung
Reaktionsgleichung
[Cl:1][C:2]1[CH:29]=[CH:28][C:5]([C:6]([N:8]2[CH2:14][C:13]3[CH:15]=[CH:16][CH:17]=[CH:18][C:12]=3[N:11]([CH2:19][C:20]([O:22]C(C)(C)C)=[O:21])[C:10](=[O:27])[CH2:9]2)=[O:7])=[CH:4][CH:3]=1.[F:30][C:31]([F:36])([F:35])[C:32]([OH:34])=[O:33]>ClCCl>[F:30][C:31]([F:36])([F:35])[C:32]([OH:34])=[O:33].[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:6]([N:8]2[CH2:14][C:13]3[CH:15]=[CH:16][CH:17]=[CH:18][C:12]=3[N:11]([CH2:19][C:20]([OH:22])=[O:21])[C:10](=[O:27])[CH2:9]2)=[O:7])=[CH:28][CH:29]=1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
400 mg (0.97 mmol) of t-butyl [4-(4-chlorobenzoyl)-2-oxo-2,3,4,5-tetrahydrobenzo[e][1,4]diazepin-1-yl]acetate was dissolved in a mixture of 2 ml of dichloromethane and 2 ml of trifluoroacetic acid, and the obtained solution was stirred at room temperature for 1 hour. The solvent was evaporated to obtain the crude title compound.
Aufarbeitung
- customThe solvent was evaporated
Quellen und Nachweise
- ORD-Eintrag
- ord-e0c7f1ac54244cbab4822c886f82a94f
- Quelldatensatz
- uspto-grants-2004_11
- Patentnummer
- US06825191B2
Notizen zur Reaktion
Wird geladen…